Clinical Trial Update: Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Denosumab (AMG 162) in Japanese Postmenopausal Women [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating denosumab (AMG 162) safety, tolerability, pharmacokinetics, and pharmacodynamics in Japanese postmenopausal women with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Denosumab (denosumab)

Snippet

Sponsor: Amgen | Conditions: Osteoporosis | Phase 1 | Status: COMPLETED | Results posted: 2019-07-24